Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Principal Investigator
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project.
How best to interpret measures of levels of oxygen in tissues to make them effective clinical tools for care of patients with cancer and other oxygen-dependent pathologies.
PI
Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in Cancer.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in Cancer.
Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in Cancer. Cancer Treat Res. 2025; 129:309-324.
View in:
PubMed
subject areas
Drug Resistance, Neoplasm
Humans
Immunotherapy
Neoplasms
Phenotype
authors with profiles
Ravi Salgia